Locations
Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2020
Cajal Neuroscience is a drug discovery company focused on neurodegenerative diseases, utilizing high-throughput microscopy, functional genomics, and multi-omics analyses to identify new drug targets and therapeutics. The company aims to generate novel disease-altering therapies, leveraging a passionate team of scientists and advanced technologies to position itself as a leader in the neurodegeneration market. With a commitment to innovation and scientific excellence, Cajal Neuroscience is poised to make significant contributions to the treatment of conditions like Alzheimer's and Parkinson's disease.
Something looks off?On-site & Remote